Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
243.89B | 237.07B | 225.07B | 290.99B | 269.75B | 185.99B | Gross Profit |
38.68B | 37.34B | 28.81B | 31.28B | 26.48B | 13.42B | EBIT |
24.06B | 22.32B | 15.30B | 16.39B | 19.21B | 6.02B | EBITDA |
24.59B | 34.64B | 28.53B | 24.66B | 27.73B | 14.95B | Net Income Common Stockholders |
13.71B | 12.40B | 6.72B | 10.84B | 7.79B | 1.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
27.08B | 24.21B | 26.12B | 16.82B | 18.55B | 10.71B | Total Assets |
226.13B | 215.90B | 211.76B | 212.35B | 192.38B | 194.90B | Total Debt |
58.80B | 55.13B | 58.49B | 86.46B | 88.60B | 92.23B | Net Debt |
32.72B | 32.92B | 37.38B | 69.64B | 70.75B | 82.59B | Total Liabilities |
108.39B | 103.85B | 112.87B | 124.59B | 119.59B | 123.73B | Stockholders Equity |
73.23B | 69.19B | 60.60B | 54.40B | 57.26B | 54.33B |
Cash Flow | Free Cash Flow | ||||
13.53B | 22.45B | 20.33B | 22.99B | 26.09B | 9.84B | Operating Cash Flow |
9.97B | 32.81B | 27.04B | 27.75B | 28.23B | 14.88B | Investing Cash Flow |
-10.88B | -7.63B | -11.18B | -3.42B | -744.30M | 1.93B | Financing Cash Flow |
-18.69B | -22.93B | -14.14B | -27.04B | -18.48B | -15.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$14.78B | 5.37 | 20.63% | 3.77% | ― | ― | ||
51 Neutral | $2.02B | -1.14 | -21.37% | 3.64% | 2.88% | -30.57% | |
$8.99B | 6.66 | 9.58% | 4.52% | ― | ― | ||
$65.81B | 12.45 | 27.63% | 2.27% | ― | ― | ||
€2.77B | 7.32 | 19.19% | 3.92% | ― | ― | ||
81 Outperform | HK$135.42B | 5.70 | 22.43% | 11.04% | 14.65% | 93.98% | |
79 Outperform | HK$3.18B | 3.55 | 14.76% | 8.48% | 6.80% | 1.55% |